PLANET PHARMA — Diclofenac Importer Profile
Pharmaceutical Importer · #6 buyer for Diclofenac · $8.2M import value · 329 shipments · FRANCE · DGFT Verified
PLANET PHARMA is the #6 importer of Diclofenac from India with $8.2M in import value and 329 verified shipments. PLANET PHARMA holds a 2.8% market share in Diclofenac imports based in FRANCE. The company sources from 14 verified suppliers across 139 formulations shipped to 5 countries. Overall, PLANET PHARMA imports 24 pharmaceutical products worth $40.8M across 10 therapeutic categories.
PLANET PHARMA — Diclofenac Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Diclofenac to PLANET PHARMA?
Verified from 329 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| TROIKAA PHARMACEUTICALS LIMITED | $6.5M | 184 | 80.0% |
| SUN PHARMACEUTICAL INDUSTRIES LIMITED | $785.2K | 43 | 9.6% |
| LINCOLN PHARMACEUTICALS LIMITED | $381.1K | 25 | 4.7% |
| AUROCHEM PHARMACEUTICALS (INDIA) PRIVATELIMITED | $230.0K | 17 | 2.8% |
| RENA EXPORTS PRIVATE LIMITED | $89.9K | 15 | 1.1% |
| AUROCHEM PHARMACEUTICALS INDIA PRIVATE LIMITED | $60.9K | 4 | 0.7% |
| INDOLANDS PHARMA PRIVATE LIMITED | $24.4K | 18 | 0.3% |
| AUROCHEM PHARMACEUTICALS INDIA PRIVATELIMITED | $23.9K | 4 | 0.3% |
| AHAAN HEALTHCARE PRIVATE LIMITED | $16.1K | 7 | 0.2% |
| SONVO LIFE SCIENCES | $9.9K | 6 | 0.1% |
| BAL PHARMA LIMITED | $6.5K | 1 | 0.1% |
| J B CHEMICALS AND PHARMACEUTICALS LIMITED | $5.5K | 1 | 0.1% |
| EAST AFRICAN INDIA OVERSEAS | $3.4K | 2 | 0.0% |
| FREDUN PHARMACEUTICALS LIMITED | $0 | 2 | 0.0% |
PLANET PHARMA sources Diclofenac from 14 verified Indian suppliers based on 329 customs records. The primary supplier is TROIKAA PHARMACEUTICALS LIMITED accounting for 80.0% of imports.
How Does PLANET PHARMA Compare to Nearest Diclofenac Importers?
Buyers ranked immediately above and below #6 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | CIPLA USA INC UPS SUPPLY CHAIN SOLU | UNITED STATES | $20.5M | 990 | $20.7K |
| 6 | PLANET PHARMA ★ | FRANCE | $10.1M | 202 | $50.0K |
| 9 | DR. REDDY'S LABORATORIES, INC | UNITED STATES | $4.7M | 93 | $50.0K |
| 7 | NUEVOS ETICOS NEOETHICALS, S.A. | GUATEMALA | $4.2M | 84 | $50.0K |
PLANET PHARMA ranks #6 among 2,731 Diclofenac importers from India. Average shipment value of $50.0K compared to the market average of $21.4K. The closest competitors by value are CIPLA USA INC UPS SUPPLY CHAIN SOLU and DR. REDDY'S LABORATORIES, INC.
Where Does PLANET PHARMA Import Diclofenac To?
Destination countries from 329 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| FRANCE | $8.1M | 322 | 99.5% |
| TANZANIA | $32.9K | 3 | 0.4% |
| ZIMBABWE | $6.5K | 1 | 0.1% |
| KENYA | $5.5K | 1 | 0.1% |
| UGANDA | $0 | 2 | 0.0% |
PLANET PHARMA imports Diclofenac to 5 countries. The primary destination is FRANCE receiving 99.5% of shipments worth $8.1M.
What Diclofenac Formulations Does PLANET PHARMA Import?
| Formulation | Value | Shipments |
|---|---|---|
| DYNAPAR DICLOFENAC SODIUM AND PARACETAMO | $1.1M | 25 |
| DYNAPAR QPS 30ML DICLOFENAC DIETHYLAMINE | $500.3K | 11 |
| DYNAPAR QPS DICLOFENAC DIETHYLAMINE AND | $435.1K | 11 |
| DYNAPAR AQ DICLOFENAC SODIUM INJECTION 7 | $412.2K | 12 |
| PHARMACEUTICALS FORMULATIONS DYNAPAR DICLOFENAC SODIUM AND PARACETAMOL TABLETS SHELF LIFE: 48 MONTH 10X10 TABNOS | $303.8K | 8 |
| PHARMACEUTICALS FORMULATIONS DYNAPAR DICLOFENAC SODIUM AND PARACETAMOL TABLETS 10X10 TAB SHELF LIFE: 48 MONTHNOS | $274.2K | 6 |
| DYNAPAR GEL30 GM ALPHA LINOLENIC ACID &DICLOFENAC DIETHYLAMINE METHYL SALICYLATE & MENTHOL GEL, OTH AS PER INV & PLNOS | $263.6K | 15 |
| DYNAPAR DICLOFENAC SODIUM AND PARACETAMOL TABLETS OTHER DETAILS AS PER INV PL | $250.0K | 5 |
| Diclofenac Sodium Injection 75 mg/3 ml ( | $213.1K | 12 |
| DYNAPAR DICLOFENAC SODIUM AND PARACETAMOL TABLETS OTH AS PER INV & PL | $211.2K | 5 |
PLANET PHARMA imports 139 distinct Diclofenac formulations from India. The top formulation is DYNAPAR DICLOFENAC SODIUM AND PARACETAMO with 25 shipments worth $1.1M.
Who Are the Top Buyers of Diclofenac from India and How Much Does PLANET PHARMA Import?
India exported $58.4M worth of Diclofenac through 15,000 shipments from 1007 suppliers to 173 countries, serving 2,731 buyers globally. PLANET PHARMA imports $8.2M of this total, accounting for 2.8% of India's Diclofenac exports with 329 shipments from FRANCE. This is verified from 329 customs shipment records covering 139 distinct formulations.
What Is the Average Order Value for PLANET PHARMA's Diclofenac Imports?
PLANET PHARMA's average Diclofenac order value is $24.9K per consignment, based on 329 shipments totaling $8.2M. PLANET PHARMA is based in FRANCE and ranks #6 among all Diclofenac importers from India by value. The company sources from 14 verified suppliers in India.
Who Supplies Diclofenac to PLANET PHARMA?
PLANET PHARMA sources Diclofenac from 14 verified Indian suppliers: TROIKAA PHARMACEUTICALS LIMITED ($6.5M, 80.0%), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($785.2K, 9.6%), LINCOLN PHARMACEUTICALS LIMITED ($381.1K, 4.7%), AUROCHEM PHARMACEUTICALS (INDIA) PRIVATELIMITED ($230.0K, 2.8%), RENA EXPORTS PRIVATE LIMITED ($89.9K, 1.1%). This is based on 329 customs records.
How Does PLANET PHARMA Compare to Other Diclofenac Importers?
PLANET PHARMA ranks #6 among 2,731 Diclofenac importers from India with a 2.8% market share. The top 3 importers are CIPLA USA INC UPS SUPPLY CHAIN SOLU ($20.5M), PLANET PHARMA ($10.1M), DR. REDDY'S LABORATORIES, INC ($4.7M). PLANET PHARMA processed 329 shipments from FRANCE.
What Other Analgesics & Antipyretics Products Does PLANET PHARMA Import?
PLANET PHARMA also imports these analgesics & antipyretics products. Each links to the detailed product page.
About PLANET PHARMA
PLANET PHARMA imports 24 products worth $40.8M. Beyond Diclofenac, top products include Sodium, Metronidazole, Cefixime, Folic, Phenylephrine. View the complete PLANET PHARMA profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Diclofenac — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Diclofenac shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: PLANET PHARMA matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as PLANET PHARMA's capped import value divided by total capped export value for Diclofenac across all Indian exporters.
- 5.Verified Records: This page is backed by 329 individual customs records matching PLANET PHARMA importing Diclofenac, covering 139 formulations from 14 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 173+ countries, 2,731+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Diclofenac Import Data for PLANET PHARMA
Access order-level details, pricing data, supplier connections, and competitive analysis for PLANET PHARMA's Diclofenac imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
PLANET PHARMA
Full Company Profile →
24 products · $40.8M total trade · 10 categories
PLANET PHARMA × Diclofenac
Verified from customs records
Company Overview
Top Products by PLANET PHARMA
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for PLANET PHARMA.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Diclofenac. For current order-level data, contact TransData Nexus.